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Abstract
Background: To examine the blood glucose profile and the relationship between blood glucose levels and
neurodevelopmental outcome in term infants with hypoxic-ischaemic encephalopathy.
Methods: Blood glucose values within 72 hours of birth were collected from 52 term infants with hypoxic-
ischaemic encephalopathy. Hypoglycaemia [< 46.8 mg/dL (2.6 mmol/L)] and hyperglycaemia [> 150 mg/dL (8.3
mmol/L)] were correlated to neurodevelopmental outcome at 24 months of age.
Results: Four fifths of the 468 blood samples were in the normoglycaemic range (392/468:83.8%). Of the
remaining 76 samples, 51.3% were in the hypoglycaemic range and (48.7%) were hyperglycaemic. A quarter of the
hypoglycaemic samples (28.2%:11/39) and a third of the hyperglycaemic samples (32.4%:12/37) were recorded
within the first 30 minutes of life. Mean (SD) blood glucose values did not differ between infants with normal and
abnormal outcomes [4.89(2.28) mmol/L and 5.02(2.35) mmol/L, p value = 0.15] respectively. In term infants with
hypoxic-ischaemic encephalopathy, early hypoglycaemia (between 0-6 hours of life) was associated with adverse
outcome at 24 months of age [OR = 5.8, CI = 1.04-32)]. On multivariate analysis to adjust for grade of HIE this
association was not statistically significant. Late hypoglycaemia (6-72 hours of life) was not associated with
abnormal outcome [OR = 0.22, CI (0.04-1.14)]. The occurrence of hyperglycaemia was not associated with adverse
outcome.
Conclusion: During the first 72 hours of life, blood glucose profile in infants with hypoxic-ischaemic
encephalopathy varies widely despite a management protocol. Early hypoglycaemia (0-6 hours of life) was
associated with severe HIE, and thereby; adverse outcome.
Background
Hypoxic-ischaemic encephalopathy (HIE) remains an
important cause of neonatal death and long-term neuro-
disability [1]. Goals of management have been to main-
tain normoxaemia, normocapnia, normoglycaemia and
normal blood pressure to avoid or ameliorate secondary
cerebral injuries [2].
Neonatal hypoglycaemia, independent of HIE, has
been associated with adverse outcome in both term and
preterm infants [3-5]. However, no conclusive evidence
on the severity and duration of hypoglycaemia causing
brain damage has been reported [6,7]. Basu et al showed
that the degree of hypoglycaemia was correlated to the
severity of HIE in term asphyxiated newborns [8]. In
term infants with severe fetal acidemia, an association
between early adverse outcome and hypoglycaemia on
the first blood sample was reported by Salhab et al [9].
These studies did not address long-term neurodevelop-
mental outcome. The mechanism of hypoglycaemic
brain injury has been examined in animal models.
Hypoglycaemia decreases the cerebrovascular response
to hypoxia and increases cerebral superoxide production
and aspartate levels into the brain extracellular space
resulting in neuronal necrosis [10-12].
Hyperglycaemia is associated with adverse outcome in
premature infants, in critically ill children and in adult
patients with stroke [13-18]. In extremely low birth
weight infants and in patients in paediatric intensive
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care unit, controlling elevated blood glucose levels by
controlled insulin infusion was associated with good
short-term outcome [19,20]. However, no data on long-
term neurodevelopmental outcome relating to hypergly-
caemia in neonatal HIE has been reported [19,20]. The
mechanism of hyperglycaemic brain damage is thought
to be related to neuronal cell apoptosis following
reperfusion with high level of substrate (glucose) in an
ATP- deleted cell. In an animal model, hyperglycaemia
following hypoxic-ischaemic insult decreases fetal brain
ATP and oxygen consumption and increases thickness
of vascular endothelium with foci of infarction [21-23].
In the absence of long-term neurodevelopmental out-
comes on the effects of early hypoglycaemia and hyper-
glycaemia in HIE, the aim of this study was to describe
the early blood glucose profile and to determine whether
hypoglycaemia and hyperglycaemia in the 72 hours of
birth were associated with adverse neurodevelopmental
outcome at 24 months of age in infants with HIE.
Methods
This study was a retrospective analysis of a prospective
cohort of babies with HIE, none of whom received
therapeutic hypothermia. It was conducted in a large
maternity hospital with an annual delivery rate of
approximately 5000 babies. Ethical approval was
obtained from Cork University Hospital Research Ethics
Committee. Informed consent was obtained from all
parents of the infants who were enrolled in the study.
We examined the medical notes of a cohort of 55 term
infants with HIE, recruited prospectively at birth
between May 2003 and December 2005. Term infants
were recruited to the cohort if they fulfilled 2 or more
of the following criteria:
• Initial capillary or arterial pH < 7.1
• Apgar score < 5 at 5 minutes
• Initial capillary or arterial lactate > 7 mmol/l
• Abnormal neurology or clinical seizures.
Demographics and data related to neonatal course,
ventilation variables and the arterial, capillary and venous
blood glucose values of the first 3 days of life were
retrieved from the medical notes. All infants with HIE
had blood glucose levels checked within the first 30 min-
utes after delivery. Blood glucose values were collected
from either arterial, venous, or capillary samples. An on-
site analyser (Radiometer) was used to measure blood
glucose levels. Hypoglycaemia and hyperglycaemia were
defined as blood glucose levels < 46.8 mg/dL (2.6 mmol/
L) and > 150 mg/dL (8.3 mmol) respectively [5,13].
Hypoglycaemia was treated with an initial parenteral
bolus of 2 mL/kg of a 10% dextrose solution over one
minute. Blood glucose levels were rechecked 30 minutes
to 1 hour later according to the severity of hypoglycae-
mia. Dextrose infusion rate or concentration was
adjusted to maintain blood glucose level > 50 mg/dL
(2.8 mmol/L). In infants with hyperglycaemia, the rate
or concentration of glucose infusion was adjusted to
maintain blood glucose within normal levels.
Demographic details and clinical data were recorded
in each case. Clinical grade of encephalopathy was
assigned using a Sarnat score at 24 hours of age. Neuro-
developmental outcome was assessed at 24 months
using the Revised Griffith’s scales of Mental Develop-
ment [24]. Adverse outcome was defined as death, a
Griffith’s Quotient (GQ) less than 87, or significant
motor disability. Statistical analysis was performed using
SPSS version 14.0 for Windows. Summary measures
were calculated and are reported as mean and standard
deviation (SD) or median and (range). Spearman corre-
lation was used to explore the differences in categorical
variables. Univariate and multivariate logistic regression
models were used to estimate odds ratios and 95% con-
fidence intervals. A p value <0.05 was considered statis-
tically significant.
Results
Demographics (table 1)
Fifty-two of the 55 infants completed follow up to
24 months. Mean (SD) gestational age was 39 weeks+1
day (1.5 weeks), mean (SD) birth weight was 3.45 (0.58)
Kgs. Four infants were delivered at home, and therefore
accurate details of Apgar scores and resuscitation details
were not available. More than 1 bolus of dextrose infu-
sion was required in four infants. All infants who
required increased glucose infusions experienced stable
blood glucose within 2 hours of birth.
72-hour glucose profile
In total, 468 blood glucose samples were analyzed. Four
out of 5 samples were in the normoglycaemic range
(392/468: 83.8%). Of the remaining 76 samples, half
(51.3%) were in the hypoglycaemic range and less than
half were hyperglycaemic (48.7%).
The median timing of initial blood glucose sampling
was 25 and 80 minutes after birth (range 9-30 and
70-100 minutes) in inborn and outborn infants respec-
tively. More than one third of all blood samples [177/
468 (37.8%)] were documented within the first 6 hours
of birth. A quarter of the hypoglycaemic (28.2%: 11/39)
and a third of the hyperglycaemic samples (32.4%:12/37)
were recorded on the first blood samples. Fifty percent
(20/39) of the hypoglycaemic and 90% (33/37) of the
hyperglycaemic samples were recorded within the first
6 hours of life (figure 1).
Of the 52 infants in the cohort, mild, moderate and
severe HIE was seen in 25, 18 and 9 infants, respectively.
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The mean (SD) number of blood glucose samples, taken
in the first 72 hours, was 5.9 (2.9), 11.5 (5.7) and 13.1
(3.6) in infants with mild, moderate and severe HIE,
respectively.
Mean glucose levels and outcome
Abnormal neuro-developmental outcome at 24 months
of age was documented in 21 (40.4%) infants. Mean
(SD) blood glucose values did not differ between infants
with normal or abnormal outcomes [4.89 (2.28) mmol/L
and 5.02 (2.35) mmol/L, p value = 0.15] respectively.
The distribution of blood glucose levels (mmol/L)
in individual infants according to outcome is depicted
in figure 2.
HIE grade, glucose profile and outcome
Mean (SD) of blood glucose level was 4.7 (1.8), 4.9 (2.4)
and 5.3 (2.5) mmol/L in infants with mild, moderate
and severe HIE respectively, (p value 0.10). The occur-
rence of early hypoglycaemia correlated significantly
with severe HIE (p = 0.012). Twenty-five infants had
mild HIE, of whom 23/25 (92%) had a normal outcome.
Moderate HIE occurred in 18 infants, of whom 10/18
(55.6%) had abnormal outcome. The nine infants with
severe HIE all had an abnormal outcome.
Infants with normoglycaemia, hypoglycaemia and
hyperglycaemia and outcome (table 2)
The relationship between early (0-6 hours of life) and
late (6-72 hours of life) blood glucose levels and adverse
outcome at 24 months of age in infants with HIE is pre-
sented in table 2. Early hypoglycaemia (0-6 hours of life)
was associated with adverse outcome (OR = 5.8, (CI =
1.04-32). Late hypoglycaemia (between 6-72 hours of
life) and early and late hyperglycaemia (0- 6 and 6-72
Table 1 Demographic data
Total number of infants, n 52
Male, n (%) 34/52 (65.4%)
Infants required ETT at
delivery, n (%)
32/52 (61.5%)
Infants required CPR at
delivery, n (%)
13/52 (25%)
Birth Weight, median
(range)
3.54(1.83-5.04)
Gestational age (weeks
+days), median (range)
40+1(35+6-42+1)
Apgar at 1 minute, median
(range)
4 (0-9)
Apgar at 5 minutes,
median (range)
6 (2-10)
Blood glucose, median
(range)
4.5 mmol/L [81 mg/dL], (0.3-17 mmol/L
[5.4-306 mg/dL])
Abnormal outcome, n (%) 21/52 (40.4%), of those 2 infants had mild,
10 had moderate and 9 had severe HIE
Seizures 12/52 (23%)
Mortality Mild HIE: 0/25
Moderate HIE: 2/18 (11%)
Severe HIE: 2/9 (22%)
Apgar scores were not available in 4 infants with planned home deliveries;
ETT = Endotracheal tube; CRP = Cardiopulmonary resuscitation.
Figure 1 Distribution of blood glucose levels (mmol/L) according to the timing of blood glucose sample after delivery. Horizontal lines
represent normal range of blood glucose.
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hours of life, respectively) were not associated with
adverse outcome (table 2). Univariate followed by multi-
variate analysis had been performed.
By univariate analysis, three variables were associated
with adverse outcome: early hypoglycaemia, Apgar score
≤ 5 at five minutes and severe HIE (p value 0.025, 0.035
and <0.001 respectively). Moderate HIE, Apgar score at
1 minute, number of blood samples per subject and the
requirement for intubation at birth were not signifi-
cantly associated with adverse outcome. On multivariate
analysis only moderate (p = 0.024) and severe (p <
0.001) HIE grade remained significantly associated with
adverse outcome.
Discussion
This study is the first to describe the blood glucose pro-
file during the first 72 hours of life in infants with HIE.
Despite a protocolised-driven approach to detecting and
treating abnormal blood sugars following perinatal
asphyxia in our unit, sustained normoglycaemia in the
first 72 hours of birth was observed in only half of our
infants with HIE.
What does the glucose profile in HIE tell us? Abnor-
mal blood glucose values were observed in 1 out of 6
samples. Less than a third of hypoglycaemia and hyper-
glycaemia episodes were observed on the first blood
sample taken within a half-hour of birth. However, half
of hypoglycaemic samples and 90% of hyperglycaemic
samples occurred within 6 hours of birth. These findings
suggest that many asphyxiated babies, in addition to
facing an hypoxic-ischaemic insult, are concurrently
experiencing significant variations in blood sugars in the
early newborn period. The hypoglycaemic episodes may
be due to perinatal depletion of glycogen stores (many
asphyxiated babies are post mature), whilst the hypergly-
caemic episodes may reflect the release of stress-related
hormones. In addition, since variations in blood glucose
levels persist throughout the first 72 hours, this study
indicates that regular measurements of the blood glu-
cose should continue throughout this period.
In our study, early hypoglycaemia was associated with
an increased risk of adverse outcome at 24 months of
age in infants with HIE. However, when corrected for
grade of HIE this was no longer significant. Our results
are consistent with the findings of Salhab et al. In that
study, hypoglycaemia on the initial blood sample after
birth was associated with abnormal short-term outcomes
(death as a consequence of severe encephalopathy and
Table 2 Relationship between blood glucose levels and adverse outcome in term infants with HIE (n = 52; however in
7 infants there were both hypoglycaemic and hyperglycaemic episodes documented, explaining the overlap)
No. of infants (n = 52) No. of infants
With abnormal outcome
Risk of adverse outcome
OR (CI)
Normoglycaemia 24/52 9/24 (37.5%) OR = 0.8, (CI = 0.26-2.44)
Early hypoglycaemia (0-6 hours of life) 8/52 6/8 (75%) OR = 5.8, (CI = 1.04-32)
Late hypoglycaemia (6-72 hours of life) 12/52 2/12 (8.3%) OR = 0.22, (CI = 0.04-1.14)
Early hyperglycaemia (0-6 hours of life) 11/52 4/11 (36.4%) OR = 0.81, (CI = 0.2-3.2)
Late hyperglycaemia (6-72 hours of life) 4/52 2/4 (50%) OR = 1.53, (CI = 0.2-11.8)
Figure 2 Distribution of blood glucose levels (mmol/L) in individual infants (n = 52) by neurodevelopmental outcome at 24 months.
Horizontal lines represent normal range of blood glucose. The boxes and whiskers represent the ranges between 25th and 75th percentiles and
between 10th and 90th percentiles respectively. The circles (outliers) represent cases with values that are between 1.5 and 3 box lengths from
either end of the box. Asterisks (extremes) represent cases with values more than 3 box lengths from rather end of the box.
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evidence of moderate to severe encephalopathy with or
without seizures) in term infants with severe fetal acid-
aemia [9]. However no long term outcome has been
reported from that group. In preterm infants, it has
been shown that hypoglycaemia was associated with
mental and motor development scores at age of
18 months corrected. However at age of 8 years, only
arithmetic and motor scores were affected [5,25]. It has
been shown that intracranial MRI abnormalities in full
term infants with neonatal hypoglycaemia are resolved
two months later [26]. Hypoglycaemia has been asso-
ciated with abnormal neurological outcomes but not
with abnormal psychomotor development [3,27,28].
Available data on the relationship between hypergly-
caemia and adverse outcome is inconclusive [13,15]. In
infant rats, it has been shown that hyperglycaemia dur-
ing an hypoxic-ischaemic insult can have a beneficial
effect against brain injury [29]. LeBlanc et al showed
that, in newborn piglets, hyperglycaemia after hypoxic-
ischaemic injury does not worsen the brain injury [30].
In newborn piglets, Park et al showed that brain energy
metabolism was affected by hyperglycaemia during the
immediate reperfusion period after hypoxic-ischaemic
brain insult [21]. In fetal sheep, Blomstrand S et al
showed that hyperglycemia during asphyxia reduces cer-
ebral oxygen consumption and increases acidosis [22].
Hyperglycaemia following hypoxia-ischaemia insult was
shown to be harmful, in adult rats [23].
However the glucose values studied were beyond those
we see in clinical situation in humans. Despite the data
on ELBW infants [13-15] and experience with older chil-
dren [16,17], the ideal management of hyperglycaemia in
neonatal encephalopathy remains unclear [19,20].
There are some limitations to the current study. Data
was available in only 52 patients who are part of an
ongoing study of continuous early EEG in HIE. The
association between blood glucose and neuro-develop-
mental outcome was not an a priori outcome in this
study. Standard blood sampling was not possible, since
in emergency situations, blood glucose samples were
collected from arterial, capillary or venous blood which
may independently affect glucose levels. Initial blood
glucose samples were collected within 30 and 100 min-
utes after delivery in inborn and outborn infants respec-
tively. These were repeated between 30 minutes and
4 hours, as clinically indicated. It is, therefore, possible
that there were variations in blood glucose values that
were missed in between measurements. Finally this
cohort of neonates with HIE was recruited prior to
introduction of therapeutic hypothermia as a standard
of care. Whether variations in blood glucose will affect
neuro-developmental outcome in infants treated with
therapeutic hypothermia remains to be seen.
Conclusion
We conclude that it is difficult to avoid hypoglycaemia
and/or hyperglycaemia in infants with HIE, since such
variations in blood glucose levels often occur soon after
birth, and may be related to the asphyxial process. In
term infants with HIE, glucose profiles vary widely during
the first 72 hours of life. Early hypoglycaemia occurs
more frequently in infants with severe HIE, and is there-
fore associated with abnormal outcome. The further
exploration of the relationship between glycaemic control
and neurological outcome will require larger numbers of
patients and continuous blood glucose monitoring.
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